Iris de Rink
Impact in
- Immunology top 10%
- Immune cells in cancer
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
Papers in
- Immunology 11
- T-cell and B-cell Immunology 4
- Immune Cell Function and Interaction 3
- Immune cells in cancer 3
- Immunotherapy and Immune Responses 2
-
- Epigenetics and DNA Methylation 4
- Cancer-related gene regulation 3
- Wnt/β-catenin signaling in development and cancer 2
- Co-authors
- Jos Jonkers (3 shared papers)Lodewyk F.A. Wessels (5 shared papers)Ton N. Schumacher (2 shared papers)Maarten Slagter (2 shared papers)Anne Paulien Drenth (2 shared papers)Karin E. de Visser (2 shared papers)Wilbert Zwart (2 shared papers)Stefan Preković (1 shared paper)
- Journals
- Nature Communications (2 papers)Proceedings of the National Academy of Sciences (2 papers)Cancer Cell (2 papers)Cancer Immunology Immunotherapy (1 paper)Cancer Research (1 paper)
- Partner nations
- NetherlandsUnited StatesUnited Kingdom
In The Last Decade
Iris de Rink
19 papers receiving 911 citations
Iris de Rink's Hit Papers
Peers
Comparison fields: 5 of 77
- Immunology 293
- Oncology 314
- Cancer Research 131
- Molecular Biology 444
- Immunology and Allergy 19
Countries citing papers authored by Iris de Rink
This map shows the geographic impact of Iris de Rink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris de Rink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris de Rink more than expected).
Fields of papers citing papers by Iris de Rink
This network shows the impact of papers produced by Iris de Rink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris de Rink. The network helps show where Iris de Rink may publish in the future.
Co-authors
The 25 scholars most cited alongside Iris de Rink, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis Hit paper breakdown → | 2019 | 369 |
| 2 | 2013 | 99 | |
| 3 | 2018 | 72 | |
| 4 | 2023 | 67 | |
| 5 | 2024 | 48 | |
| 6 | 2023 | 46 | |
| 7 | 2016 | 46 | |
| 8 | 2017 | 38 | |
| 9 | 2017 | 37 | |
| 10 | 2021 | 30 | |
| 11 | 2021 | 16 | |
| 12 | 2016 | 12 | |
| 13 | 2019 | 9 | |
| 14 | 2021 | 8 | |
| 15 | 2020 | 6 | |
| 16 | 2025 | 5 | |
| 17 | 2022 | 3 | |
| 18 | 2020 | 2 | |
| 19 | 2012 | 1 |
About Iris de Rink
Iris de Rink is a scholar working on Immunology, Molecular Biology, Oncology, Cell Biology and Dermatology, having authored 19 papers that have together received 914 indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Epigenetics and DNA Methylation (4 papers), Cancer-related gene regulation (3 papers), Immune Cell Function and Interaction (3 papers), Immune cells in cancer (3 papers), Wnt/β-catenin signaling in development and cancer (2 papers) and Immunotherapy and Immune Responses (2 papers). The work is most often cited by research in Immunology (293 citations), Oncology (314 citations), Cancer Research (131 citations), Molecular Biology (444 citations) and Immunology and Allergy (19 citations). Iris de Rink has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Jos Jonkers, Lodewyk F.A. Wessels, Ton N. Schumacher, Maarten Slagter, Anne Paulien Drenth, Karin E. de Visser, Wilbert Zwart, Stefan Preković, Sjors M. Kas and Danique E. M. Duits. Their work appears in journals such as Nature Communications, Proceedings of the National Academy of Sciences, Cancer Cell, Cancer Immunology Immunotherapy and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.